Single-cell ligand–receptor profiling reveals an immunotherapy-responsive subtype and prognostic signature in triple-negative breast cancer
BackgroundTriple-negative breast cancer (TNBC) is an aggressive form of cancer that lacks specific targeted therapies. Although ligand–receptor (LR) interactions play a crucial role in intercellular communication and contribute to tumor heterogeneity, their molecular details and potential as prognos...
Saved in:
| Main Authors: | Chuanzhi Chen, Jiahui Qi, Weichao Lin, Chunlan Fu, Xin Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1590951/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
by: Xinran Wang, et al.
Published: (2025-05-01) -
Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis
by: Shihao Sun, et al.
Published: (2025-08-01) -
Correction: Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer
by: Chenxi Wang, et al.
Published: (2025-08-01) -
Caveolin-1 in Tumour Cells is Predominately Expressed in the Basal Subtype of Triple-Negative Breast Carcinoma
by: Savelina Popovska, et al.
Published: (2014-11-01) -
PML localization in tumor associated macrophages as a prognostic marker in triple negative breast cancer
by: Bianca Vezzani, et al.
Published: (2025-07-01)